Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography
Prospective Cohort Study for Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography in Patients With Chronic Liver Disease and Healthy Liver/Kidney Donors
1 other identifier
observational
150
1 country
1
Brief Summary
This is a prospective cohort Study for evaluation of liver fibrosis staging with acoustic radiation force impulse elastography in patients with chronic liver disease and healthy liver/kidney donors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 21, 2011
CompletedFirst Posted
Study publicly available on registry
January 25, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedFebruary 2, 2012
February 1, 2012
9 months
January 21, 2011
February 1, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of ARFI velocity in healthy donors and patients with chronic liver disease
Measurement of ARFI velocity is non-invsive ultrasonographic technique. It is performed with a abdominal convex probe which is same probe as conventional ultrasonography. Short-duration acoustic radiation forces result in shear-wave propagation away from the region of excitation and are tracked using ultrasonic correlation-based methods. This results are called ARFI velocity which is expressed as meters per second
2 years
Study Arms (2)
chronic liver disease
Any cause of liver disease that involves a process of progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis such as hepatitis B, hepatitis C, alcoholic liver disease.
Healthy liver and kidney donor
Healthy liver and kidney donor who have normal liver condition
Interventions
Acoustic radiation force impulse (ARFI) imaging were measured 10 times in each patient.The region of interest was chosen in an area where the normal liver parenchyma was at least 6 cm thick and free of large blood vessels was chosen. A measurement depth of 2 cm below the liver capsule was chosen to standardize the examination.
Eligibility Criteria
Patients with chronic liver disease, Healthy liver and kidney donors
You may qualify if:
- Age \> 20 years
- chronic liver disease (hepatitis B, hepatitis C, liver cirrhosis) patients who are planned to liver biopsy
- Healthy liver and kidney donors
- The patients who is willing and able to provide written informed consent to participate in this study
You may not qualify if:
- Decompensated liver cirrhosis
- Patients with liver congestion due to heart dysfunction
- Patients who previously take antiviral agent and antifibrotic agent
- Healthy liver and kidney donors with any laboratory abnormalities regarding liver condition (Platelet count \< 150 x 103/ul, Fasting glucose \> 110 mg/dl, AST \> 40 IU/L, ALT\> 40 IU/L, Albumin \< 3.3 g/dl, Total bilirubin \> 1.2 mg/dl, GGT\> 54 IU/L, ALP \> 115 IU/L , Ferritin \> 322 ng/ml)
- A history of any other medical disease or condition that would make the patients unsuitable for this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yonsei Universitylead
- Severance Hospitalcollaborator
Study Sites (1)
Severance Hospital
Seoul, 120-752, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kwang-Hyub Han, MD
Department of Internal Medicine, Yonsei University College of Medicine
- PRINCIPAL INVESTIGATOR
Seung Up Kim, MD
Department of Internal Medicine, Yonsei University College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2011
First Posted
January 25, 2011
Study Start
July 1, 2010
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
February 2, 2012
Record last verified: 2012-02